The purpose of this study was to lower body core temperature prior to a simulated portion of a triathlon (swim-15min; bike-45min) and examine whether precooling could attenuate thermal strain and increase subjective exercise tolerance in the heat. Six endurance trained triathletes (mean ± SE, 28 ± 2 yr, 8.2 ± 1.7 % body fat) completed two randomly-assigned trials, one week apart. The precooling trial (PC) involved lowering body core temperature (-0.5°C) in water prior to swimming and cycling. The control trial (CON) was identical except no precooling was performed. Water temperature and environmental conditions were maintained at -25.6°C and -26.6°C/60% RH respectively, throughout all testing. Mean time to precool was 31:37 ± 8:03 and average time to reach baseline temperature during cycling was 9:35 ± 7:60. Oxygen consumption (VO2), heart rate (HR), rate of perceived exertion (RPE), thermal sensation (TS), and skin (Tsk) and core (Ta) temperatures were recorded following the swim segment and throughout cycling. No significant differences in mean body (TO or Tsk were noted between PC and CON, but a significant difference (P<0.05) in T, between treatments was noted through the early phases of cycling. No significant differences were reported in HR, V02, RPE, TS or sweat rate (SR) between treatments. Body heat storage (S) was negative following swimming in both PC (92 ± 6 W/m2) and CON (66 ± 9 W/m2). A greater increase in S occurred in PC (109 ± 6 W/m2) vs. CON (79 ±4 W/m2) during cycling (P<0.05) . Precooling attenuated the rise in T,, but this effect was transient. Based on the results from this study, precooling is not recommended prior to endurance exercise in the heat. / School of Physical Education

Sepsis-induced organ failure is associated with high morbidity and mortality rates. The onset of an exaggerated host response to microbial invasion and/or trauma, is believed to be the primary cause of excessive inflammation and the subsequent tissue hypoperfusion observed in patients with severe sepsis. In our mouse model of sepsis induced by cecal ligation and perforation (CLP), symptoms indicative of the disease, including diarrhea, increased ventilation and persistent hypothermia, are present at six hours after the surgery (T6). In the untreated CLP mice, mortality occurs starting at T15. As induced hypothermia has shown to exert immunomodulatory effects, this study is aimed at assessing its potential in attenuating inflammation and improving survival in experimental sepsis. Our data has shown that deep hypothermia initiated at T6, by means of cold chamber-induced cooling, prolongs survival. Plasma cytokine quantification by enzyme-linked immunosorbent assays (ELISA) also reveals that induced deep hypothermia reduces tumour necrosis factor(TNF)-α and interleukin (IL)-6 production in untreated CLP mice. In contrast, induced moderate hypothermia does not have such effect. Antibiotic (cefotaxime) and saline resuscitation initiated immediately following CLP ensures survival. However, when these supportive treatments are initiated at T6, >50% mortality is observed in the CLP mice with or without induced hypothermia. In summary, this preliminary study provides proof for a downregulated inflammatory response mediated by external cooling. However, to achieve a survival benefit, treatment strategies in addition to cooling and antibiotics may be required.

Sepsis-induced organ failure is associated with high morbidity and mortality rates. The onset of an exaggerated host response to microbial invasion and/or trauma, is believed to be the primary cause of excessive inflammation and the subsequent tissue hypoperfusion observed in patients with severe sepsis. In our mouse model of sepsis induced by cecal ligation and perforation (CLP), symptoms indicative of the disease, including diarrhea, increased ventilation and persistent hypothermia, are present at six hours after the surgery (T6). In the untreated CLP mice, mortality occurs starting at T15. As induced hypothermia has shown to exert immunomodulatory effects, this study is aimed at assessing its potential in attenuating inflammation and improving survival in experimental sepsis. Our data has shown that deep hypothermia initiated at T6, by means of cold chamber-induced cooling, prolongs survival. Plasma cytokine quantification by enzyme-linked immunosorbent assays (ELISA) also reveals that induced deep hypothermia reduces tumour necrosis factor(TNF)-α and interleukin (IL)-6 production in untreated CLP mice. In contrast, induced moderate hypothermia does not have such effect. Antibiotic (cefotaxime) and saline resuscitation initiated immediately following CLP ensures survival. However, when these supportive treatments are initiated at T6, >50% mortality is observed in the CLP mice with or without induced hypothermia. In summary, this preliminary study provides proof for a downregulated inflammatory response mediated by external cooling. However, to achieve a survival benefit, treatment strategies in addition to cooling and antibiotics may be required.

La réalisation d’une performance sportive dans un environnement chaud est un challenge majeur que doivent surmonter les athlètes de haut niveau notamment à l’occasion des Jeux Olympiques d’été. Depuis plusieurs décennies, les scientifiques ont tenté de trouver des solutions innovantes. Parmi les réponses proposées, on distingue aujourd’hui le refroidissement corporel préalable ou consécutif à l’effort (le pré et le post-cooling, respectivement), qui permettrait de minimiser les risques d’hyperthermie et améliorerait la récupération de l’athlète. Cependant, les modalités d’utilisation de ces méthodes et leur efficacité font l’objet de conclusions pour le moins contradictoires en raison notamment des techniques de refroidissement mises en œuvre (refroidissement par immersion, vêtements thermorégulants, brumisation…), de la durée d’application, du type d’exercice réalisé et des conditions environnementales explorées. La préparation des Jeux Olympiques à Pékin, en Août 2008, a été une occasion unique de faire un état de l’art sur les méthodes existantes. Nous avons testé chez des cyclistes de haut niveau l’hypothèse selon laquelle une stratégie de refroidissement utilisant une veste garnie d’accumulateurs thermiques permettrait d’améliorer le confort thermique et la performance lors d’un exercice de type anaérobie (Wingate test) et lors d’une épreuve d’endurance de 20 minutes. L’étude menée sur le test de Wingate ne montre aucun effet significatif du pré-cooling sur le pic de puissance ni sur la puissance moyenne mais permet néanmoins d’améliorer significativement (P < 0,05) l’indice de fatigue des athlètes testés. Sur l’épreuve de 20 minutes, le pré-cooling permet une amélioration significative (P < 0,05) de la puissance moyenne développée, du confort thermique et une baisse significative des températures cutanées et rectales. Une autre étude portant sur l’influence de différents maillots sur les réponses physiologiques et perceptives de coureurs cyclistes a montré qu’un maillot constitué de larges mailles offrait un meilleur confort thermique en diminuant significativement (P < 0,05) la température cutanée, mais sans modifier la perception de l’effort. Les bénéfices observés chez les cyclistes de haut niveau nous ont orientés vers la mise en œuvre d’un protocole similaire appliqué à des personnes atteintes de pathologies affectant la thermorégulation. Ainsi, nous avons débuté un protocole de recherche clinique exploratoire visant à étudier les effets du port d’une veste thermorégulante sur les performances motrices et cognitives de patients atteints de sclérose en plaques. Ce protocole, qui a obtenu l’accord du Comité de Protection des Personnes du Grand Est –II, devrait commencer fin 2012. / Abstract: Exercising in the heat and high relative humidity is a major challenge that athletes have to overcome, especially during the summer Olympic Games. For decades, scientists investigated innovative solutions amongst which the body cooling before competing (pre-cooling) or after competing (post-cooling) seemed to be a valuable mean of minimizing hyperthermia threats and increasing the recovery of the athletes. However, contradictory results have been reported concerning body cooling protocols (cold water immersion, cooling vests, water sprays, etc.), exposure time, exercise duration, environmental conditions and their efficiency. By preparing the 2008 Beijing Olympic Games, we managed to review the existing literature on those methods. We hypothesized that a cooling vest combined with a cooling headband would increase thermal comfort of elite cyclists and their performances on an anaerobic (Wingate Test) and endurance (20 minutes time-trial) exercises. The Wingate Test study showed no significant effect of pre-cooling on peak or mean power output despite a significant increase (P < 0.05) of fatigue indexes. During the endurance study, pre-cooling maneuvers induced significant improvement (P < 0.05) of the mean power output, of the thermal comfort and a significant decrease in rectal and skin temperatures. Another study concerning the influence of wearing different cycling shirt on perceived and physiological responses of cyclists showed that a large knitted shirt provided a better thermal comfort by decreasing significantly (P < 0.05) skin temperatures, but without affecting perceived exertion. Those positive results on elite athletes lead us to apply similar cooling strategies on a population experiencing disease-related thermoregulation troubles. We decided to initiate an exploratory clinical study aiming at investigating the effects of a cooling vest on motor and cognitive skills of patients with multiple sclerosis disease. This protocol obtained the clearance of the French National Ethics Committee – East Section II, and should start on the late of 2012.

Sepsis-induced organ failure is associated with high morbidity and mortality rates. The onset of an exaggerated host response to microbial invasion and/or trauma, is believed to be the primary cause of excessive inflammation and the subsequent tissue hypoperfusion observed in patients with severe sepsis. In our mouse model of sepsis induced by cecal ligation and perforation (CLP), symptoms indicative of the disease, including diarrhea, increased ventilation and persistent hypothermia, are present at six hours after the surgery (T6). In the untreated CLP mice, mortality occurs starting at T15. As induced hypothermia has shown to exert immunomodulatory effects, this study is aimed at assessing its potential in attenuating inflammation and improving survival in experimental sepsis. Our data has shown that deep hypothermia initiated at T6, by means of cold chamber-induced cooling, prolongs survival. Plasma cytokine quantification by enzyme-linked immunosorbent assays (ELISA) also reveals that induced deep hypothermia reduces tumour necrosis factor(TNF)-α and interleukin (IL)-6 production in untreated CLP mice. In contrast, induced moderate hypothermia does not have such effect. Antibiotic (cefotaxime) and saline resuscitation initiated immediately following CLP ensures survival. However, when these supportive treatments are initiated at T6, >50% mortality is observed in the CLP mice with or without induced hypothermia. In summary, this preliminary study provides proof for a downregulated inflammatory response mediated by external cooling. However, to achieve a survival benefit, treatment strategies in addition to cooling and antibiotics may be required.

La réalisation d’une performance sportive dans un environnement chaud est un challenge majeur que doivent surmonter les athlètes de haut niveau notamment à l’occasion des Jeux Olympiques d’été. Depuis plusieurs décennies, les scientifiques ont tenté de trouver des solutions innovantes. Parmi les réponses proposées, on distingue aujourd’hui le refroidissement corporel préalable ou consécutif à l’effort (le pré et le post-cooling, respectivement), qui permettrait de minimiser les risques d’hyperthermie et améliorerait la récupération de l’athlète. Cependant, les modalités d’utilisation de ces méthodes et leur efficacité font l’objet de conclusions pour le moins contradictoires en raison notamment des techniques de refroidissement mises en œuvre (refroidissement par immersion, vêtements thermorégulants, brumisation…), de la durée d’application, du type d’exercice réalisé et des conditions environnementales explorées. La préparation des Jeux Olympiques à Pékin, en Août 2008, a été une occasion unique de faire un état de l’art sur les méthodes existantes. Nous avons testé chez des cyclistes de haut niveau l’hypothèse selon laquelle une stratégie de refroidissement utilisant une veste garnie d’accumulateurs thermiques permettrait d’améliorer le confort thermique et la performance lors d’un exercice de type anaérobie (Wingate test) et lors d’une épreuve d’endurance de 20 minutes. L’étude menée sur le test de Wingate ne montre aucun effet significatif du pré-cooling sur le pic de puissance ni sur la puissance moyenne mais permet néanmoins d’améliorer significativement (P < 0,05) l’indice de fatigue des athlètes testés. Sur l’épreuve de 20 minutes, le pré-cooling permet une amélioration significative (P < 0,05) de la puissance moyenne développée, du confort thermique et une baisse significative des températures cutanées et rectales. Une autre étude portant sur l’influence de différents maillots sur les réponses physiologiques et perceptives de coureurs cyclistes a montré qu’un maillot constitué de larges mailles offrait un meilleur confort thermique en diminuant significativement (P < 0,05) la température cutanée, mais sans modifier la perception de l’effort. Les bénéfices observés chez les cyclistes de haut niveau nous ont orientés vers la mise en œuvre d’un protocole similaire appliqué à des personnes atteintes de pathologies affectant la thermorégulation. Ainsi, nous avons débuté un protocole de recherche clinique exploratoire visant à étudier les effets du port d’une veste thermorégulante sur les performances motrices et cognitives de patients atteints de sclérose en plaques. Ce protocole, qui a obtenu l’accord du Comité de Protection des Personnes du Grand Est –II, devrait commencer fin 2012. / Abstract: Exercising in the heat and high relative humidity is a major challenge that athletes have to overcome, especially during the summer Olympic Games. For decades, scientists investigated innovative solutions amongst which the body cooling before competing (pre-cooling) or after competing (post-cooling) seemed to be a valuable mean of minimizing hyperthermia threats and increasing the recovery of the athletes. However, contradictory results have been reported concerning body cooling protocols (cold water immersion, cooling vests, water sprays, etc.), exposure time, exercise duration, environmental conditions and their efficiency. By preparing the 2008 Beijing Olympic Games, we managed to review the existing literature on those methods. We hypothesized that a cooling vest combined with a cooling headband would increase thermal comfort of elite cyclists and their performances on an anaerobic (Wingate Test) and endurance (20 minutes time-trial) exercises. The Wingate Test study showed no significant effect of pre-cooling on peak or mean power output despite a significant increase (P < 0.05) of fatigue indexes. During the endurance study, pre-cooling maneuvers induced significant improvement (P < 0.05) of the mean power output, of the thermal comfort and a significant decrease in rectal and skin temperatures. Another study concerning the influence of wearing different cycling shirt on perceived and physiological responses of cyclists showed that a large knitted shirt provided a better thermal comfort by decreasing significantly (P < 0.05) skin temperatures, but without affecting perceived exertion. Those positive results on elite athletes lead us to apply similar cooling strategies on a population experiencing disease-related thermoregulation troubles. We decided to initiate an exploratory clinical study aiming at investigating the effects of a cooling vest on motor and cognitive skills of patients with multiple sclerosis disease. This protocol obtained the clearance of the French National Ethics Committee – East Section II, and should start on the late of 2012.

Sepsis-induced organ failure is associated with high morbidity and mortality rates. The onset of an exaggerated host response to microbial invasion and/or trauma, is believed to be the primary cause of excessive inflammation and the subsequent tissue hypoperfusion observed in patients with severe sepsis. In our mouse model of sepsis induced by cecal ligation and perforation (CLP), symptoms indicative of the disease, including diarrhea, increased ventilation and persistent hypothermia, are present at six hours after the surgery (T6). In the untreated CLP mice, mortality occurs starting at T15. As induced hypothermia has shown to exert immunomodulatory effects, this study is aimed at assessing its potential in attenuating inflammation and improving survival in experimental sepsis. Our data has shown that deep hypothermia initiated at T6, by means of cold chamber-induced cooling, prolongs survival. Plasma cytokine quantification by enzyme-linked immunosorbent assays (ELISA) also reveals that induced deep hypothermia reduces tumour necrosis factor(TNF)-α and interleukin (IL)-6 production in untreated CLP mice. In contrast, induced moderate hypothermia does not have such effect. Antibiotic (cefotaxime) and saline resuscitation initiated immediately following CLP ensures survival. However, when these supportive treatments are initiated at T6, >50% mortality is observed in the CLP mice with or without induced hypothermia. In summary, this preliminary study provides proof for a downregulated inflammatory response mediated by external cooling. However, to achieve a survival benefit, treatment strategies in addition to cooling and antibiotics may be required.